Summary & Overview
CPT 0466U: CardioRisk+ Polygenic Risk Assessment for Acquired Heart Disease
CPT code 0466U designates a proprietary laboratory analysis for the CardioRisk+ test from Gene by Gene Ltd. and OpenDNA Ltd. The test combines DNA from a buccal swab with patient lifestyle and clinical data to generate an algorithmic polygenic risk estimate for acquired heart disease. As a PLA code tied to a single manufacturer and test, 0466U is relevant for payers and providers navigating coverage, medical necessity review, and billing for genomic risk assessments.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a national-level overview of where this code fits in clinical workflows and billing systems, plus what to expect when encountering 0466U on claims. The publication outlines typical sites of service and the clinical context for use—genetic susceptibility assessment using buccal swab specimens—as well as common operational considerations for payer adjudication and claim submission.
This analysis provides benchmarks and policy context relevant to genomic proprietary tests, summaries of payer coverage posture where available, and practical coding information to support billing professionals and laboratory administrators handling claims for CardioRisk+ under CPT code 0466U.
Billing Code Overview
CPT code 0466U is a Proprietary Laboratory Analyses (PLA) code that applies exclusively to the CardioRisk+ test from Gene by Gene Ltd. and OpenDNA Ltd. The test analyzes DNA collected via a buccal (cheek) swab and integrates genetic data with patient lifestyle and clinical information to produce an algorithmic assessment of polygenic risk for acquired heart disease. This reporting reflects an individual’s genetic susceptibility to heart disease rather than a diagnostic result for current disease.
Service type: Proprietary laboratory genetic risk analysis
Typical site of service: Clinical laboratory or diagnostic laboratory processing specimens collected in outpatient settings (buccal swab collection)
Clinical & Coding Specifications
Clinical Context
A 52-year-old adult with a family history of premature coronary artery disease and elevated lifetime cardiovascular risk requests genomic risk assessment. The clinician orders the CardioRisk+ proprietary test to quantify polygenic susceptibility to acquired heart disease. The patient presents to an outpatient clinic or a certified phlebotomy center; a buccal (cheek) swab sample is collected per manufacturer instructions, demographic and lifestyle data (smoking status, BMI, diet, physical activity) and relevant clinical data (personal history of hypertension, hyperlipidemia, diabetes, current medications) are recorded and securely transmitted to the testing laboratory (Gene by Gene Ltd. / OpenDNA Ltd.). The laboratory performs DNA extraction, genotyping, and an algorithmic analysis that integrates genomic markers with the supplied lifestyle and clinical variables to produce a polygenic risk score for acquired heart disease. Test results are returned to the ordering clinician with an interpretation report indicating relative genetic risk compared to population norms. Typical sites of service include outpatient primary care clinics, cardiology clinics, preventive medicine clinics, and certified laboratory specimen collection centers. Billing uses the PLA code 0466U to report the CardioRisk+ test. Common clinical uses include risk stratification discussions, shared decision-making about preventive strategies, and informing consideration of early lifestyle or pharmacologic interventions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Unspecified modifier (used by some payors as default) | Rarely used; include only if the billing system requires a placeholder and no other modifier applies. |
22 | Increased procedural services | Use when documentation supports substantially greater clinical labor or complexity by the lab or provider beyond usual processing (rare for standardized PLA tests).
52 | Reduced services | Use when the test or algorithm was partially completed or limited (for example, insufficient lifestyle data prevented full algorithm run) and documentation supports reduced service.
53 | Discontinued procedure | Use if specimen collection was attempted but aborted prior to completion for documented clinical reasons.
RT | Right side (anatomic) | Data not applicable to this procedure; not typically used for buccal swab tests.
LT | Left side (anatomic) | Data not applicable to this procedure; not typically used for buccal swab tests.
59 | Distinct procedural service | Use only when another distinct, separately reportable service was performed on the same date and documentation supports distinctness from the PLA test.
91 | Repeat clinical diagnostic laboratory test | Use if the test was repeated on the same day to obtain confirmatory specimen due to initial invalid result.
KX | Requirements specified in the medical policy are met | Use when the payer requires attestation that medical necessity requirements are met and documentation supports it (payer-dependent).
NU | New equipment; new supplies | Typically not applicable to PLA coding but may be used by facility billing when new testing platform incurs additional charges and payer policy allows.
| Taxonomy Code | Specialty | Notes |
|---|---|---|
208000000X | Family Medicine | Primary care clinicians commonly order genetic risk assessments for preventive risk stratification. |
207RF0000X | Cardiovascular Disease (Cardiology) | Cardiologists may order or interpret polygenic risk results in context of cardiac risk management.
207K00000X | Preventive Medicine | Preventive medicine specialists integrate genomic risk into population health and prevention strategies.
208D00000X | Internal Medicine | Internists routinely order and follow up on risk assessment testing for chronic disease prevention.
208100000X | Clinical Laboratory Director | Laboratory physicians/directors oversee testing quality, result interpretation, and reporting.
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
E78.5 | Hyperlipidemia, unspecified | Hyperlipidemia is a common cardiometabolic risk factor; polygenic risk results inform overall cardiovascular risk stratification. |
I10 | Essential (primary) hypertension | Hypertension is a major acquired cardiovascular risk factor often considered alongside genetic susceptibility.
E11.9 | Type 2 diabetes mellitus without complications | Diabetes substantially increases risk of coronary artery disease; relevant when integrating polygenic risk with clinical data.
Z83.42 | Family history of ischemic heart disease and other diseases of the circulatory system | Family history often prompts genomic risk testing to clarify inherited susceptibility.
Z13.6 | Encounter for screening for cardiovascular disorders | CardioRisk+ may be ordered as part of preventive cardiovascular screening in asymptomatic individuals.
I25.10 | Atherosclerotic heart disease of native coronary artery without angina pectoris | Used when assessing secondary prevention risk and when genetic risk may inform management in established disease.
R73.03 | Prediabetes | Prediabetes increases lifetime cardiovascular risk; relevant for comprehensive risk assessment that includes genetic predisposition.
Z00.00 | Encounter for general adult medical examination without abnormal findings | Asymptomatic adults presenting for preventive care may receive polygenic risk testing to inform personalized prevention.
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
0466U | CardioRisk+ (proprietary PLA): DNA analysis from buccal swab integrated with lifestyle and clinical data to report polygenic risk for acquired heart disease | Principal billing code for the CardioRisk+ test; used by the performing lab (Gene by Gene Ltd. / OpenDNA Ltd.). |
99000 | Handling and/or conveyance of specimen for transfer from physician's office to a laboratory | May be billed by some providers or courier services when specimens are transported to the performing laboratory (billing practices vary by payer).
36415 | Collection of venous blood by venipuncture | Not typically required for buccal swab testing; included when additional blood tests are ordered same visit for complementary risk assessment (lipid panel, glucose).
81002 | Urinalysis, non-automated, without microscopy | Example of common ancillary tests performed during cardiovascular risk evaluation visit; not directly related to the PLA but often part of the overall assessment.
83036 | Hemoglobin; glycosylated (A1C) | Common companion laboratory test for assessing cardiometabolic risk performed before or after genetic risk testing.
80061 | Lipid panel (total, HDL, LDL, triglycerides) | Frequently ordered alongside genetic risk testing to provide current biochemical cardiovascular risk data that complements polygenic risk results.